Kentucky’s public higher education institutions have joined forces for a commercialisation drive part funded by a $1.2m grant from state-run entrepreneurship hub KY Innovation.
The institute has secured grant funding to coalesce its entrepreneurial services into a new centre partnered with corporates including Teva, Rafael Advanced Defense Systems and Alpha Omega.
Kyoto University Innovation Capital is partnering Infinite Capital Holding as part of efforts to let spinouts conduct clinical trials in China.
University of Kentucky will lead a consortium of academic institutions participating in a US government-funded commercialisation hub intended to accelerate biomedical research.
IP Group has joined forces with tech transfer company Crossword Cybersecurity to target the launch of more cybersecurity spinouts.
Biontech, an immunotherapy spinout of Johannes Gutenberg University Mainz, has received an undisclosed amount of equity funding as part of a collaboration deal that could reach $425m.
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.